FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis

This review describes the recently FDA-approved drugs (in the year 2022). Many of these products contain active moieties that FDA had not previously approved, either as a single ingredient or as part of a combination. These products frequently provide important new therapies for patients with multip...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Pharmaceutics
المؤلفون الرئيسيون: Davide Benedetto Tiz, Luana Bagnoli, Ornelio Rosati, Francesca Marini, Claudio Santi, Luca Sancineto
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2022-11-01
الموضوعات:
FDA
drugs
synthesis
new therapies
الوصول للمادة أونلاين:https://www.mdpi.com/1999-4923/14/11/2538

الانترنت

https://www.mdpi.com/1999-4923/14/11/2538

مواد مشابهة